Matches in SemOpenAlex for { <https://semopenalex.org/work/W4232308182> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- W4232308182 abstract "Abstract Background: Major bleeding and allogeneic transfusion leads to negative outcomes in patients receiving cardiac surgery with cardiopulmonary bypass (CPB). Ulinastatin, a urine trypsin inhibitor, relieves systemic inflammation and improves coagulation profiles with however sparse evidence of its effects on blood loss and allogeneic transfusion in this specific population.Methods: In this prospective randomized controlled trial, 426 consecutive patients receiving open heart surgery with CPB were randomly assigned into three groups to receive ulinastatin (group U, n=142), tranexamic acid (group T, n=143) or normal saline (group C, n=141). The primary outcome was the total volume of post-operative bleeding and the secondary outcome included the volume and exposure of allogeneic transfusion, the incidence of stroke, post-operative myocardial infarction, renal failure, respiratory failure and all-cause mortality. A ten-year follow-up was carried on to evaluate long-term outcomes.Results: Compared with placebo, ulinastatin significantly reduced the total volume of post-operative blood loss (801.7±460.14ml vs 1016.67±529.08ml, MD -214.98ml, p<0.001) and the volume of allogeneic erythrocyte transfusion (2.57±3.15 unit vs 3.73±4.21 unit, MD-1.16 unit, p=0.002). The bleeding and transfusion outcomes were comparable between the ulinastatin group and the tranexamic acid group. In-hospital outcomes and 10-year follow-up showed no statistical difference in mortality and major morbidity among groups.Conclusion: Ulinastatin reduced post-operative blood loss and allogeneic erythrocyte transfusion in open heart surgery with CPB. The mortality and major morbidity was comparable among the groups shown by the 10-year follow-up.Trial registration: The trial was retrospectively registered on February 2, 2010. Trial registration number: https://www.clinicaltrials.gov. Identifier: NCT01060189." @default.
- W4232308182 created "2022-05-12" @default.
- W4232308182 creator A5001743625 @default.
- W4232308182 creator A5010184003 @default.
- W4232308182 creator A5013214103 @default.
- W4232308182 creator A5029360035 @default.
- W4232308182 creator A5031667877 @default.
- W4232308182 creator A5055843995 @default.
- W4232308182 creator A5071798264 @default.
- W4232308182 creator A5085395896 @default.
- W4232308182 date "2020-02-25" @default.
- W4232308182 modified "2023-10-16" @default.
- W4232308182 title "Effect of ulinastatin on post-operative blood loss and allogeneic transfusion in patients receiving cardiac surgery with cardiopulmonary bypass: a prospective randomized controlled study with 10-year follow-up" @default.
- W4232308182 doi "https://doi.org/10.21203/rs.2.24411/v1" @default.
- W4232308182 hasPublicationYear "2020" @default.
- W4232308182 type Work @default.
- W4232308182 citedByCount "0" @default.
- W4232308182 crossrefType "posted-content" @default.
- W4232308182 hasAuthorship W4232308182A5001743625 @default.
- W4232308182 hasAuthorship W4232308182A5010184003 @default.
- W4232308182 hasAuthorship W4232308182A5013214103 @default.
- W4232308182 hasAuthorship W4232308182A5029360035 @default.
- W4232308182 hasAuthorship W4232308182A5031667877 @default.
- W4232308182 hasAuthorship W4232308182A5055843995 @default.
- W4232308182 hasAuthorship W4232308182A5071798264 @default.
- W4232308182 hasAuthorship W4232308182A5085395896 @default.
- W4232308182 hasBestOaLocation W42323081821 @default.
- W4232308182 hasConcept C126322002 @default.
- W4232308182 hasConcept C141071460 @default.
- W4232308182 hasConcept C2776376669 @default.
- W4232308182 hasConcept C2778789114 @default.
- W4232308182 hasConcept C2778881276 @default.
- W4232308182 hasConcept C2779637338 @default.
- W4232308182 hasConcept C2780014101 @default.
- W4232308182 hasConcept C2781246285 @default.
- W4232308182 hasConcept C2908647359 @default.
- W4232308182 hasConcept C2991743468 @default.
- W4232308182 hasConcept C42219234 @default.
- W4232308182 hasConcept C71924100 @default.
- W4232308182 hasConcept C99454951 @default.
- W4232308182 hasConceptScore W4232308182C126322002 @default.
- W4232308182 hasConceptScore W4232308182C141071460 @default.
- W4232308182 hasConceptScore W4232308182C2776376669 @default.
- W4232308182 hasConceptScore W4232308182C2778789114 @default.
- W4232308182 hasConceptScore W4232308182C2778881276 @default.
- W4232308182 hasConceptScore W4232308182C2779637338 @default.
- W4232308182 hasConceptScore W4232308182C2780014101 @default.
- W4232308182 hasConceptScore W4232308182C2781246285 @default.
- W4232308182 hasConceptScore W4232308182C2908647359 @default.
- W4232308182 hasConceptScore W4232308182C2991743468 @default.
- W4232308182 hasConceptScore W4232308182C42219234 @default.
- W4232308182 hasConceptScore W4232308182C71924100 @default.
- W4232308182 hasConceptScore W4232308182C99454951 @default.
- W4232308182 hasLocation W42323081821 @default.
- W4232308182 hasLocation W42323081822 @default.
- W4232308182 hasLocation W42323081823 @default.
- W4232308182 hasOpenAccess W4232308182 @default.
- W4232308182 hasPrimaryLocation W42323081821 @default.
- W4232308182 hasRelatedWork W2049733093 @default.
- W4232308182 hasRelatedWork W2086235024 @default.
- W4232308182 hasRelatedWork W2148898940 @default.
- W4232308182 hasRelatedWork W2328659429 @default.
- W4232308182 hasRelatedWork W2332193474 @default.
- W4232308182 hasRelatedWork W2354492445 @default.
- W4232308182 hasRelatedWork W2390543330 @default.
- W4232308182 hasRelatedWork W2901292015 @default.
- W4232308182 hasRelatedWork W3009399736 @default.
- W4232308182 hasRelatedWork W3017135163 @default.
- W4232308182 isParatext "false" @default.
- W4232308182 isRetracted "false" @default.
- W4232308182 workType "article" @default.